Current research has shown that Prox1 is overexpressed in tumor tissues, such as kidney cancer and gastric cancer, while downregulated in tumor tissues, such as primary liver cancer, indicating that it may play different roles in different tumor tissues [11]. This evidence concerns the gene PROX1 and neoplasm.